This webinar offered a practical overview of how impurities in biological medicines are identified, evaluated, and controlled under both European and U.S. regulatory frameworks.
If you require any further information, contact us at: [email protected]

By department
By stage of development
By product
By region
Other services
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
